Accuracy Check: Pseudogout Risk Factors
The listed risk factors are largely accurate, with strong evidence supporting hyperparathyroidism, hemochromatosis, hypothyroidism, and low magnesium as established associations with pseudogout (CPPD disease). However, the evidence for acromegaly, low phosphate, and Wilson's disease is weaker or indirect.
Strongly Supported Risk Factors
Hyperparathyroidism
This is a well-established risk factor. Patients with CPPD are three times more likely to have primary hyperparathyroidism than those without CPPD (OR=3.03,95% CI 1.15 to 8.02) 1. Meta-analysis confirms this association, and hyperparathyroidism patients may have increased risk of acute CPP crystal arthritis attacks 1. The mechanism involves altered calcium-phosphate metabolism that promotes crystal deposition 2.
Hemochromatosis
This stands out as the most clinically significant association. Hemochromatosis uniquely associates not only with chondrocalcinosis but also with structural joint changes and chronic arthropathy—unlike other metabolic conditions 2. This makes it particularly important to screen for in younger patients presenting with pseudogout 3, 4.
Hypothyroidism
Meta-analysis suggests a small but significant association between hypothyroidism and chondrocalcinosis 2. This is recognized in clinical practice as one of the endocrine disorders causing chondrocalcinosis and pseudogout manifestations 5.
Low Magnesium (Hypomagnesemia)
This is a well-documented risk factor. Hypomagnesemia clearly associates with chondrocalcinosis and acute pseudogout attacks 2. The mechanism is direct: magnesium depletion promotes CPP crystal formation, and magnesium can solubilize CPP crystals in vitro 1. Gitelman syndrome, which causes chronic hypomagnesemia, demonstrates this association clearly 6. Always screen for magnesium depletion when evaluating chondrocalcinosis 6.
Weakly Supported or Questionable Risk Factors
Low Phosphate
The evidence here is indirect and conflicting. While hypophosphatemia occurs in hyperparathyroidism (which is associated with pseudogout), low phosphate itself is not established as an independent risk factor for CPPD. The guideline evidence discusses hypophosphatemia primarily in the context of hyperparathyroidism complications 7, not as a direct cause of pseudogout. This should be listed with caution or removed from the risk factor list.
Acromegaly
Limited evidence supports this association. One research article mentions acromegaly among endocrine causes of chondrocalcinosis 5, but this is not substantiated by the higher-quality guideline evidence or meta-analyses. The 2025 guideline on hyperparathyroidism differential diagnosis mentions acromegaly can cause hypercalcemia 7, but does not establish a direct link to CPPD. This association is weak and should be considered questionable.
Wilson's Disease
This is mentioned in case reports but lacks strong evidence. Wilson's disease appears in one case report as a condition to investigate in young patients with pseudogout 3, but the primary guideline evidence on Wilson's disease 8, 9 focuses on acute liver failure and does not mention CPPD or pseudogout. The hypoparathyroidism guidelines mention copper deposits can infiltrate parathyroid glands 10, but this causes hypoparathyroidism, not hyperparathyroidism or pseudogout. This association is poorly supported and should be questioned.
Clinical Recommendations
When evaluating patients with chondrocalcinosis or pseudogout, screen for:
- Primary hyperparathyroidism (serum calcium, PTH)
- Hemochromatosis (iron studies, ferritin, transferrin saturation)—especially in younger patients or those with chronic arthropathy
- Hypothyroidism (TSH, free T4)
- Hypomagnesemia (serum magnesium)—this is often overlooked but important 6
Consider hypophosphatasia (alkaline phosphatase) as an additional validated risk factor not on your original list 2.
Common Pitfall
Do not assume all metabolic associations are equally strong. Hemochromatosis is unique in causing structural arthropathy, while other conditions primarily associate with chondrocalcinosis and acute attacks 2. Young patients presenting with pseudogout warrant more aggressive metabolic screening, as they are more likely to have an underlying disorder 3, 4.